BERTIS


Proteomics

dealing with ‘proteins,’ actual signs of disease manifestations

Proteomics is a broad field of research that yields clinically valuable information
for the good of disease diagnosis and treatment.

WHY PROTEOMICS?

Unlike a genome that is a blueprint for the human body,
the proteome is a phenotype that reflects the functional traits actually expressed.
Thus, proteome data offers more valuable clinical information in real-time.

Proteomics is a field that studies the roles and characteristics of various proteins, as well as their interrelationships.

The proteomics research needs comprehensive analysis for vast amount of information regarding proteins
in the human body leads to not only high research complexity but also investigation is challengeable.
GLOBAL PROTEOMICS MARKET
Proteomics is a core technology to explore the feature in human health such as precision medicine and cancer treatment.
The global proteomics market, which is experiencing rapid growth, is projected to expand by over 20% annually and
is expected to reach a value of $55.9 billion by 2026.
  • Source : Proteomics Market worth $55.9 billion by 2026, markets and markets

BERTIS’ TECHNOLOGY
ProteoID (Proteome Integrated Determination) is proteomics platform technology of Bertis covered from
data generation to large-scale commercialization.

ProteoID 바로가기ProteoID 바로가기

  • Biomarker Discovery &
    Algorithms Development
    1. COFFER
    2. BTS MS
    3. BTS Reads
    4. BTS Systems
    5. PepQuant Library
  • Commercialization
    of Diagnostics
    1. Dual LC
    2. DeepMRM
  • Advanced
    Technology
    1. AmpiTAG
    2. SAN

go top